Albert David Share Price

Albert David Share Price

NSE: ALBERTDAVD
|
Pharmaceuticals

₹ 784.65

+₹3.80 (0.49%)
1D
Last updated 13 Oct, 2026, 11:24 IST

Albert David Share Price Today

As of 13 Oct 2026, Albert David share price is ₹784.65. The stock opened at ₹794.85, compared to its previous close of ₹780.85. During today's trading session, Albert David share price moved in the range of ₹784.65 to ₹794.95, with an average price of ₹789.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹579.90 and a high of ₹931.85. On the performance front, Albert David share price has increased by 6.67% over the last six months and is down 2.69% on a year-on-year basis.

₹784.65
0.49% up today
₹794.95
1D LOW
1D HIGH

Albert David Returns Calculator

Volume
1,144
Average traded price
₹790.71
Last traded time
11:24:26 13 Oct
Last traded quantity
1
Circuit
L
H
₹624.70
₹937.00
52-week
L
H
₹579.90
₹931.85
Mkt Cap Cr
451.46
P/E
19.77
P/B
1.14
ROA
4.35%
ROE
-0.38%
ROCE
0.75%
Quick Ratio
2.74
EV/EBITDA
11.18
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Albert David has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Albert David appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,21,539.1634.795.0411.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9884.6414.7714.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.2221.084.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.224.18.57%18.59%17.35%0.9114.87
Laurus Labs1,09,796.85100.720.7210.38%16.77%16.14%0.6853.86
Cipla1,05,289.7831.373.067.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4131.332.625.48%11.07%12.54%1.3515.86
Mankind Pharma97,850.3847.326.07.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.152.566.34%9.25%11.76%1.1512.47
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Albert David

Albert David Share Price
ISIN
INE155C01010
Sector Market Cap
₹ 451.46 Cr

Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.

Albert David Financial Highlights

  • Revenue: Albert David reported revenue of ₹341.05 crore in FY26 vs ₹375.35 crore in FY25. It showed a decrease of 9.14% on a yearly basis.
  • Operating Profit: Albert David reported an operating profit of ₹0.52 crore in FY26 vs ₹25.23 crore in FY25. It showed a decrease of 97.94% on a year-on-year basis.
  • Net Profit: Albert David reported a net loss of ₹1.49 crore in FY26 vs ₹17.20 crore in FY25. It showed a decrease of 108.66% on a yearly basis.

Albert David Quarterly Result Highlights

  • Albert David reported revenue of ₹129.30 crore in Jun 2026, compared with ₹61.02 crore in Mar 2026, representing an increase of 111.90% on a quarter-on-quarter (QoQ) basis.
  • Albert David reported an operating profit of ₹35.79 crore in Jun 2026, compared with ₹25.23 crore in Mar 2026, representing an increase of 241.85% on a quarter-on-quarter (QoQ) basis.
  • Albert David reported a profit of ₹32.00 crore in Jun 2026, compared with ₹21.43 crore in Mar 2026, reflecting an increase of 249.32% on a QoQ basis.
  • The earnings per share (EPS) of Albert David stood at ₹2.62 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
62.24%
FII
0.60%
Other DII
1.63%
Retail and other
35.52%
Mutual funds
0.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.60%
Mar 20260.58%
Jun 20260.57%
Sep 20260.60%
1 day
-1.36%
1 week
-6.65%
1 month
-7.52%
1 year
-2.69%
3 years
-7.79%
5 years
+25.33%
Day
Open / Close
Change %
12 Oct 26
₹787.65 / ₹780.85
-1.36%
09 Oct 26
₹790.00 / ₹791.65
-0.28%
08 Oct 26
₹810.00 / ₹793.90
-2.32%
07 Oct 26
₹827.30 / ₹812.75
-3.14%
Show more

Albert David Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹333.60₹345.77₹362.46₹341.56
Other Income₹7.45₹29.58₹57.55₹15.40
Total Revenue₹341.05₹375.35₹420.01₹356.96
Total Expenses₹340.53₹350.12₹322.73₹306.23
Profit Before Tax₹0.52₹25.23₹97.29₹50.74
Tax₹2.02₹8.03₹21.87₹14.56
Profit After Tax-₹1.49₹17.20₹75.42₹36.17
EPS - Basic-₹2.62₹30.14₹132.15₹63.39
EPS - Diluted-₹2.62₹30.14₹132.15₹63.39

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.52₹25.23₹97.29₹50.74
Income before WC changes₹12.40₹9.44₹52.84₹52.06
Change in Assets-₹5.79-₹20.43₹7.50-₹16.74
Change in Liabilities-₹9.28-₹8.94₹1.27-₹9.09
Change in WC-₹15.07-₹29.37₹8.77-₹25.84
Cash flow from Operations-₹7.66-₹28.44₹45.50₹10.52
Cash flow from Investing-₹4.40₹23.30-₹33.25-₹5.00
Cash flow from Financing₹11.92₹0.11-₹8.27-₹6.36
Total Cash Flow-₹0.14-₹5.02₹3.98-₹0.84
Cash (Start of the year)₹0.42₹5.44₹1.45₹2.28
Cash (End of the year)₹0.30₹0.42₹5.44₹1.45

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹144.73₹157.37₹126.36₹119.16
Current Assets₹374.40₹354.05₹371.63₹304.24
Total Assets₹519.13₹511.42₹497.99₹423.39
Current Liabilities₹115.43₹104.18₹99.05₹98.94
Net Current Asset₹258.97₹249.87₹272.59₹205.30
Non-Current Liabilities₹12.17₹14.75₹15.96₹12.88
Equity Capital₹391.54₹392.48₹382.98₹311.57
Total Equity & Liabilities₹519.13₹511.42₹497.99₹423.39
* All values are in INR Crore
Qty
Bid
1
785.5
2
785.25
2
785.2
35
785.1
1
784.45
Ask
Qty
790.15
1
790.4
1
790.45
2
791.4
1
791.85
7
Bid Total: 41
Ask Total: 12
Buy orders: 77%
Sell orders: 23%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
34.01
Neutral
ATR (14)
30.92
Neutral
STOCH(9,6)
4.99
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
37.03
Bearish
UO(9)
32.34
Neutral
ROC(12)
-11.12
Bearish
WillR(14)
-95.01
Bullish
Period
Simple value
Exponential vaue
5D
803.65
801.89
10D
830.69
819.98
20D
842.49
833.38
50D
831.16
820.41
100D
767.82
787.36
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Albert David Share Price
Albert David
Pharmaceuticals
Add Stock
Add Another

Albert David Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.